← Back to Search


Magnetically Controlled Capsule Endoscopy for Gastroparesis

University of California Los Angeles, Los Angeles, CA
Targeting 2 different conditionsMagnetically Controlled Capsule EndoscopyN/AWaitlist AvailableLed by Lin Chang, MDResearch Sponsored by University of California, Los Angeles

Study Summary

This trial will assess whether a magnetically controlled capsule endoscopy is a useful tool in diagnosing gastroparesis and functional dyspepsia.

Eligible Conditions
  • Gastroparesis
  • Indigestion

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You must have one of the following conditions: Gastroparesis, Functional Dyspepsia, or have undergone G-POEM procedure. Or, you can be a control subject.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dyspepsia Severity Scale symptom ratings at baseline and during the study at timepoints with discomfort if present.
Frequency and direction of contractions
Largest diameter of the pylorus
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Group I: GastroparesisExperimental Treatment1 Intervention
Patients with a diagnosis of gastroparesis meeting the inclusion criteria
Group II: G-POEMExperimental Treatment1 Intervention
Patients who received a G-POEM procedure meeting the inclusion criteria
Group III: Functional DyspepsiaExperimental Treatment1 Intervention
Patients with a diagnosis of functional dyspepsia meeting the inclusion criteria
Group IV: ControlExperimental Treatment1 Intervention
No diagnosis of gastroparesis, functional dyspepsia, or prior G-POEM

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,493 Previous Clinical Trials
10,284,597 Total Patients Enrolled
Lin Chang, MDPrincipal InvestigatorUniversity of California, Los Angeles
4 Previous Clinical Trials
153 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the enrolment figure for this clinical trial?

"Affirmative. Clinicaltrials.gov attests that this trial is currently enlisting contributors; it was first posted on the 1st of December 2021 and last updated on the 9th of January 2023, with a recruitment goal of 17 people from one facility."

Answered by AI

Are there any opportunities to participate with this experiment?

"According to the information hosted on clinicaltrials.gov, this medical study is actively seeking out participants and has been since it was first posted in December 2021. The details of the trial were last updated on January 9th 2023."

Answered by AI
~6 spots leftby Nov 2024